BeOne Medicines Ltd. SEC filings ONC
BeOne Medicines Ltd. has 1,002 filings in SEC EDGAR's recent list, going back to Nov 19, 2018. Its latest annual report, Form ARS, was filed on Apr 28, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEFA14A | Additional proxy material | Apr 28, 2026 | — |
| DEF 14A | Proxy statement | Apr 28, 2026 | Jun 11, 2026 |
| PRE 14A | Preliminary proxy statement | Apr 16, 2026 | Jun 11, 2026 |
| DEFA14A | Additional proxy material | Apr 7, 2025 | — |
| DEF 14A | Proxy statement | Apr 7, 2025 | May 21, 2025 |
| PRE 14A | Preliminary proxy statement | Mar 27, 2025 | May 21, 2025 |
| DEFA14A | Additional proxy material | Mar 10, 2025 | — |
| DEF 14A | Proxy statement | Apr 26, 2024 | Jun 5, 2024 |
| PRE 14A | Preliminary proxy statement | Apr 15, 2024 | Jun 5, 2024 |
| DEF 14A | Proxy statement | Apr 27, 2023 | — |
| PRE 14A | Preliminary proxy statement | Apr 17, 2023 | — |
| DEF 14A | Proxy statement | Apr 29, 2022 | Jun 22, 2022 |
| PRE 14A | Preliminary proxy statement | Apr 18, 2022 | Jun 22, 2022 |
| DEF 14A | Proxy statement | Apr 30, 2021 | Jun 16, 2021 |
| PRE 14A | Preliminary proxy statement | Apr 19, 2021 | Jun 16, 2021 |
| DEFA14A | Additional proxy material | Jan 29, 2021 | — |
| DEF 14A | Proxy statement | Oct 9, 2020 | Nov 20, 2020 |
| DEF 14A | Proxy statement | Apr 28, 2020 | Jun 17, 2020 |
| PRE 14A | Preliminary proxy statement | Apr 17, 2020 | Jun 17, 2020 |
| PRE 14A | Preliminary proxy statement | Mar 30, 2020 | May 14, 2020 |
| DEFA14A | Additional proxy material | Dec 6, 2019 | — |
| DEF 14A | Proxy statement | Nov 29, 2019 | Dec 27, 2019 |
| PRE 14A | Preliminary proxy statement | Nov 19, 2019 | Dec 27, 2019 |
| DEF 14A | Proxy statement | Apr 29, 2019 | Jun 5, 2019 |
| PRE 14A | Preliminary proxy statement | Apr 11, 2019 | Jun 5, 2019 |
Showing 25 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ONC (Nasdaq), BEIGF (OTC)
- Fiscal year ends
- December 31
- Headquarters
- Basel
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1651308
- Former names
- BeiGene, Ltd. (until May 27, 2025)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.